|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.7535 USD | +0.44% |
|
-3.34% | -24.65% |
Company Valuation: TScan Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 106.9 | 37.32 | 278.8 | 171.8 | 56.75 | 51.07 | - | - |
| Change | - | -65.09% | 647.03% | -38.39% | -66.96% | -10% | - | - |
| Enterprise Value (EV) 1 | -54.48 | -53.41 | 116.8 | -86.26 | -63.12 | -47.8 | -23.68 | 13.92 |
| Change | - | 1.96% | 318.71% | -173.84% | 26.82% | 24.28% | 50.45% | 158.78% |
| P/E | -1.08x | -0.56x | -4.29x | -2.67x | -1x | -0.83x | -0.77x | -0.85x |
| PBR | - | 0.37x | 1.85x | 0.71x | 0.46x | 0.56x | 0.89x | 1.28x |
| PEG | - | 0x | 0.1x | 0.2x | 0.1x | 0.09x | -0.1x | 0.09x |
| Capitalization / Revenue | 10.5x | 2.76x | 13.2x | 61x | 5.5x | 8.25x | 7.84x | 2.46x |
| EV / Revenue | -5.37x | -3.95x | 5.55x | -30.6x | -6.11x | -7.72x | -3.64x | 0.67x |
| EV / EBITDA | 1.27x | 0.94x | -1.41x | 0.71x | 0.52x | 0.37x | 0.17x | -0.11x |
| EV / EBIT | 1.12x | 0.8x | -1.25x | 0.64x | 0.46x | 0.4x | 0.18x | -0.1x |
| EV / FCF | 0.93x | 0.76x | -1.81x | 0.75x | 0.45x | 0.64x | 0.29x | -0.17x |
| FCF Yield | 108% | 132% | -55.2% | 133% | 221% | 157% | 347% | -584% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4.17 | -2.75 | -1.36 | -1.14 | -1 | -0.9025 | -0.9725 | -0.8833 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 10.14 | 13.54 | 21.05 | 2.816 | 10.32 | 6.188 | 6.511 | 20.75 |
| EBITDA 1 | -42.8 | -56.95 | -82.89 | -121.2 | -121.2 | -130.8 | -140.2 | -126.8 |
| EBIT 1 | -48.64 | -66.64 | -93.46 | -134.8 | -135.8 | -120.4 | -128.6 | -134.9 |
| Net income 1 | -48.62 | -66.22 | -89.22 | -127.5 | -129.8 | -118.8 | -130.6 | -134.1 |
| Net Debt 1 | -161.4 | -90.74 | -162 | -258 | -119.9 | -98.87 | -74.76 | -37.15 |
| Reference price 2 | 4.5000 | 1.5500 | 5.8300 | 3.0400 | 1.0000 | 0.7535 | 0.7535 | 0.7535 |
| Nbr of stocks (in thousands) | 23,761 | 24,080 | 47,825 | 56,505 | 56,748 | 67,779 | - | - |
| Announcement Date | 3/9/22 | 3/8/23 | 3/6/24 | 3/5/25 | 3/4/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83x | -7.72x | 0.37x | - | 51.07M | |
| 20.59x | 7.25x | 14.66x | 1.42% | 69.54B | |
| 36.89x | 9.62x | 29.41x | 0.04% | 64.97B | |
| -15.61x | 5.94x | -7.46x | -.--% | 25.64B | |
| -74.93x | 13.98x | -67.43x | -.--% | 25.89B | |
| 30.69x | 6.58x | 17.2x | -.--% | 26.51B | |
| 58.27x | 21.67x | 43.95x | 0.26% | 20.22B | |
| 27.27x | 5.11x | 16.98x | -.--% | 19.98B | |
| 1415.29x | 39.34x | 858.54x | -.--% | 15.69B | |
| 16.84x | 5x | 11.66x | -.--% | 13.49B | |
| Average | 151.45x | 10.68x | 91.79x | 0.19% | 28.2B | |
| Weighted average by Cap. | 93.81x | 10.79x | 57.81x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TCRX Stock
- Valuation TScan Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
